Pharmacology, Toxicology and Pharmaceutical Science
Pharmacokinetics
100%
Mouse
36%
Midazolam
25%
Carboplatin
25%
Malignant Neoplasm
17%
Farnesyl Trans Transferase
15%
Isoprenoid
12%
Disease
11%
Polypeptide Antibiotic Agent
11%
CYP3A4
10%
Anticarcinogen
9%
Plasma Protein Binding
9%
Chemotherapy
9%
Formate
9%
Pharmacokinetic Parameter
8%
Atmospheric-Pressure Chemical Ionization
8%
Pharmacodynamics
8%
Antiinfective Agent
8%
Methotrexate
8%
Lymphatic Filariasis
7%
Infectious Agent
7%
Pancreas Adenocarcinoma
7%
Ivermectin
7%
Salvinorin A
7%
Pyronaridine
7%
Inflammatory Bowel Disease
7%
Ibuprofen
7%
Clinical Pharmacokinetics
7%
Irinotecan
7%
Aldo Keto Reductase
7%
Paclitaxel
6%
Prodrug
6%
Antibiotics
6%
Multiple Myeloma
6%
Biodistribution
6%
Active Metabolite
5%
Methanol
5%
Etoposide
5%
Vincristine
5%
Neuroblastoma
5%
Nanoparticle
5%
Combination Therapy
5%
Neoplasm
5%
Creatinine
5%
Cyclophosphamide
5%
Tumor Growth
5%
Keyphrases
Pharmacokinetics
27%
Liquid Chromatography-tandem Mass Spectrometry (LC-MS/MS)
25%
Pharmacokinetic Study
22%
MS Method
20%
Carboplatin
14%
Phase I Study
11%
Plasma Concentration
9%
Hydroxychloroquine
8%
Renal Disease
8%
Newly Diagnosed
8%
Clinical Pharmacology
8%
Cerebrospinal Fluid
8%
Atmospheric Pressure Chemical Ionization
7%
Simultaneous Quantitation
7%
Hepatic Dysfunction
7%
Osteosarcoma
7%
Azithromycin
7%
Cardiopulmonary Bypass
7%
Mouse Serum
7%
Human Plasma
7%
Salvinorin
7%
Inflammatory Bowel Disease
7%
Mouse Tissue
7%
Biological Matrices
7%
Erlotinib
7%
Plasma Applications
7%
Antichlamydial Activity
7%
Docetaxel
6%
Ifosfamide
6%
Formic Acid
6%
Method Validation
5%
Etoposide
5%
High Dose
5%